Table 2.
Objective responses of liver cirrhosis patients with advanced HCC treated after 4–8 weeks of sorafenib treatment.
| Dose of sorafenib | PR | SO | PO | Response rate (%) |
|---|---|---|---|---|
| 200 m g (n = 11) (1 dropout) |
0 | 2 | 8 | 0.0 |
| 400 mg (n = 27) (3 dropout) |
4 | 11 | 9 | 16.7 |
| 800 mg (n = 7) (0 dropout) |
1 | 3 | 3 | 14.3 |